SCHEMBL8347243

SCHEMBL8347243

Cc1ccccc1OCc1cccc(N)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MRGPRX4 Q96LA9 6/20 0.49
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
RXRG P48443 1/20 0.49
SCN4A P35499 1/20 0.46
MAOA P21397 2/20 0.46
ACHE P22303 1/20 0.45
HTR1A P08908 2/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
ENPP2 Q13822 1/20 0.43
ALOX15 P16050 1/20 0.43
LTA4H P09960 1/20 0.42
MAPK14 Q16539 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8283224 0.83 FFAR4 (0.56) MAOBMAPTMAPK1TDP1L3MBTL1
SCHEMBL20631651 0.82 MAPT (0.54) MAOBMAPTMAPK1TDP1L3MBTL1
SCHEMBL12301124 0.80 MRGPRX4 (0.58) MAOBMAPTMAPK1TDP1L3MBTL1
SCHEMBL12301128 0.80 ENPP2 (0.66) MAOBMAPTMAPK1TDP1L3MBTL1
SCHEMBL15309708 0.80 MAPT (0.51) MAPTMAPK1TDP1L3MBTL1MRGPRX4
SCHEMBL12330370 0.80 MRGPRX4 (0.55) MAPTMAPK1TDP1L3MBTL1MRGPRX4
SCHEMBL8621333 0.80 MAPT (0.51) MAPTMAPK1TDP1L3MBTL1MRGPRX4
SCHEMBL20741532 0.80 RXRA (0.53) MAPTMAPK1TDP1L3MBTL1RXRA
SCHEMBL265584 0.80 MAPK1 (0.70) MAPTMAPK1TDP1L3MBTL1RXRA
SCHEMBL29874217 0.80 MAPK1 (0.70) MAPTMAPK1TDP1L3MBTL1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004009565-A2 ACYLAMINOTHIAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2004-01-29 WO disclosed